IRWD Earnings

Quarterly EPS
$0.02
Q3 2024
$0.01
Q4 2024
$-0.23
Q1 2025
$0.15
Q2 2025
$0.25
Q3 2025
$-0.01
Q4 2025
$0.25
Q1 2026
$0.31
Q2 2026
Latest Revenue113.0M
Latest Net Income51.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.31113.0M51.3M+32.6%+106.7%
Q1 2026$0.25106.5M40.8M+158.9%+208.7%
Q4 2025-$0.0147.7M-2276000-47.3%-200.0%
Q3 2025$0.25122.1M40.1M+33.3%+1,150.0%
Q2 2025$0.1585.2M23.6M-9.7%+1,600.0%
Q1 2025-$0.2341.1M-37386000-45.1%-666.7%
Q4 2024$0.0190.5M2.3M-23.0%+200.0%
Q3 2024$0.0291.6M3.6M-19.5%-80.0%
Q2 2024-$0.0194.4M-860000
Q1 2024-$0.0374.9M-4162000
Q4 2023-$0.01117.6M-1745000
Q3 2023$0.10113.7M13.9M
Ironwood Pharmaceuticals, Inc. - (IRWD) — Earnings